Adoptive Cellular Therapy (ACT) for Cancer Treatment.

about

Alcohol exposure differentially effects anti-tumor immunity in females by altering dendritic cell function.Rapid Construction of Antitumor T-cell Receptor Vectors from Frozen Tumors for Engineered T-cell Therapy.

P2860

Q40424620-3FFFC6C5-293C-496C-9B87-52A1775D7FA4 Q52626852-DE5DE312-E19A-4311-A120-EC582E1B8446

P2860

Adoptive Cellular Therapy (ACT) for Cancer Treatment.

Item

http://www.wikidata.org/entity/Q38848219

description

2016 nî lūn-bûn

@nan

2016 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

name

Adoptive Cellular Therapy (ACT) for Cancer Treatment.

@en

type

Item

label

Adoptive Cellular Therapy (ACT) for Cancer Treatment.

@en

prefLabel

Adoptive Cellular Therapy (ACT) for Cancer Treatment.

@en

P1476

Adoptive Cellular Therapy (ACT) for Cancer Treatment.

@en

P2093

Cihui Yan

http://www.w3.org/2001/XMLSchema#string

Fan Yang

http://www.w3.org/2001/XMLSchema#string

Feng Wei

http://www.w3.org/2001/XMLSchema#string

Hao Jin

http://www.w3.org/2001/XMLSchema#string

Jian Wang

http://www.w3.org/2001/XMLSchema#string

Qian Sun

http://www.w3.org/2001/XMLSchema#string

Xiubao Ren

http://www.w3.org/2001/XMLSchema#string

P2860

TCR-Engineered T Cells Meet New Challenges to Treat Solid Tumors: Choice of Antigen, T Cell Fitness, and Sensitization of Tumor Milieu

Hallmarks of Cancer: The Next Generation

The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor

Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy

Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patients

Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen

T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

P304

169-239

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/978-94-017-7555-7_4

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

909

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27240459

http://www.w3.org/2001/XMLSchema#string

Adoptive Cellular Therapy (ACT) for Cancer Treatment.

about

P2860

P2860

Adoptive Cellular Therapy (ACT) for Cancer Treatment.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698